Arkolith/Insider Trading/FATE/Form 4

Tahl Cindy

See RemarksFATE THERAPEUTICS INC (FATE) · full profile →Form 4 · filed Jan 16, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 15, 2026Grant(A)100K—$0487K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 15, 2026Grant(A)400K—$0400K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-015328) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML